101349-95-5 + 879088-41-2 = 879085-55-9 反应条件:1.1 Solvents: Methanol; Reflux1.2 Reagents: Potassium Tert-Butoxide,Oxygen,1H-Imidazolium,3-Ethyl-1-Methyl-,Tetrafluoroborate(1-) (9:10) Solvents: 1,4-Dioxane; Rt 标题:From Imines To Amides Via Nhc-Mediated Oxidation 作者:Sun,Shaofa; Et Al 参考文献:Organic Chemistry Frontiers 日期:2022 卷标:9(2) 页码:356-363]
2759099-84-6 = 879085-55-9 反应条件:1.1 Reagents: Potassium Tert-Butoxide,Oxygen,1H-Imidazolium,3-Ethyl-1-Methyl-,Tetrafluoroborate(1-) (9:10) Solvents: 1,4-Dioxane; 2 H,Rt 标题:From Imines To Amides Via Nhc-Mediated Oxidation 作者:Sun,Shaofa; Et Al 参考文献:Organic Chemistry Frontiers 日期:2022 卷标:9(2) 页码:356-363]
106904-10-3 + 1195072-76-4 = 879085-55-9 反应条件:1.1 Reagents: Sulfuric Acid Solvents: Water; 24 H,100 °C; 100 °C -> Rt1.2 Reagents: Sodium Carbonate Solvents: Water; Neutralized,Rt1.3 Reagents: Triethylamine Solvents: Tetrahydrofuran; 0 °C; 16 H,Rt 标题:Directed Meta-Selective Bromination Of Arenes With Ruthenium Catalysts 作者:Yu,Qingzhen; Et Al 参考文献:Angewandte Chemie 日期:2015 卷标:54(50) 页码:15284-15288]
80-48-8 + 2408320-20-5 = 879085-55-9 反应条件:1.1 Reagents: Tin,Sodium Pyrosulfite,Dipotassium Phosphate Catalysts: Tetrabutylammonium Bromide,1,1-Bis(Diphenylphosphino)Ferrocene,[1,1′-Bis(Diphenylphosphino)Ferrocene]Dichloropalladium Solvents: Dimethyl Sulfoxide; 10 H,100 °C 标题:Multicomponent Reductive Cross-Coupling Of An Inorganic Sulfur Dioxide Surrogate: Straightforward Construction Of Diversely Functionalized Sulfones 作者:Meng,Yingying; Et Al 参考文献:Angewandte Chemie 日期:2020 卷标:59(3) 页码:1346-1353]
879088-41-2 = 879085-55-9 [标题:Reaction Conditions 标题:Selective Hydrogenation Of Halogenated Nitroaromatics To Haloanilines In Batch And Flow 作者:Loos,Patrick; Et Al 参考文献:Organic Process Research & Development 日期:2016 卷标:20(2) 页码:452-464]
106904-10-3 + 573764-31-5 = 879085-55-9 反应条件:1.1 Solvents: Dimethylacetamide; Rt; 40 Min,40 °C2.1 Catalysts: Dichlorobis(Triphenylphosphine)Palladium Solvents: N-Methyl-2-Pyrrolidone; 20 Min,130 °C 标题:Design,Synthesis And Biological Evaluation Of Deuterated Vismodegib For Improving Pharmacokinetic Properties 作者:Wang,Fangying; Et Al 参考文献:Bioorganic & Medicinal Chemistry Letters 日期:2018 卷标:28(14) 页码:2399-2402]
55-21-0 + 1245636-12-7 = 879085-55-9 反应条件:1.1 Reagents: N,N,N′,N′-Tetramethylethylenediamine Catalysts: Cuprous Iodide Solvents: 1,4-Dioxane; 24 H,100 °C2.1 Reagents: Sulfuric Acid Solvents: Water; 24 H,100 °C; 100 °C -> Rt2.2 Reagents: Sodium Carbonate Solvents: Water; Neutralized,Rt2.3 Reagents: Triethylamine Solvents: Tetrahydrofuran; 0 °C; 16 H,Rt 标题:Directed Meta-Selective Bromination Of Arenes With Ruthenium Catalysts 作者:Yu,Qingzhen; Et Al 参考文献:Angewandte Chemie 日期:2015 卷标:54(50) 页码:15284-15288]
106904-10-3 + 879088-41-2 = 879085-55-9 反应条件:1.1 Reagents: Potassium Carbonate Solvents: Tetrahydrofuran,Water; 35 Min,2 °C; 2 °C -> 20 °C 标题:Manufacturing Development And Genotoxic Impurity Control Strategy Of The Hedgehog Pathway Inhibitor Vismodegib 作者:Angelaud,Remy; Et Al 参考文献:Organic Process Research & Development 日期:2016 卷标:20(8) 页码:1509-1519]
专利号:US-12221452-B2 优先权日:2017-10-04 标题:Synthesis of cantharidin 发明人:DAVIDSON MATTHEW GENE; EKLOV BRIAN MATTHEW; WUTS PETER; LOERTSCHER BRAD MELVIN; SCHOW STEVEN R 权利人:VERRICA PHARMACEUTICALS INC 摘要:The invention provides synthetic methods for the preparation of cantharidin and analogs thereof. In one aspect, the invention provides an improved Diels-Alder cycloaddition to generate a key intermediate en route to cantharidin and analogs thereof. In certain embodiments, the new Diels-Alder reaction involves reacting Compound (2) in the presence of furan, and in the absence of acid or increased pressure, in an aprotic polar solvent with slight warming, to yield Compound (1) in favorable yield and exo-endo ratio. In another aspect, the invention also provides a new Diels-Alder reaction between compounds of Formula (III) and furan to yield compounds of Formula (IV), which can then be transformed into cantharidin or analogs thereof. In yet another aspect, the invention describes a new palladium-mediated carbonylation providing another key intermediate en route to cantharidin and analogs thereof. In addition to synthetic methods, present invention also provides compounds (i.e., intermediates) useful in the synthesis of cantharidin and analogs thereof. Compounds provided herein may have biological activity, and therefore may be used in the treatment of diseases or conditions (e.g., infectious diseases and skin conditions).
专利号:US-2025206743-A1 优先权日:2022-03-25 标 题:Tyk2 inhibitor synthesis and intermediates thereof 发明人:MASSE CRAIG E; PHADKE AVINASH S; LAWSON JON P; LEVY STUART; YANG XIAOWEI; WU GUISHENG; FAN SHUFENG 权利人:TAKEDA PHARMACEUTICALS CO 摘要:Described herein are methods of synthesis of a tyrosine-protein kinase 2 (TYK2) inhibitor and to intermediate compounds of the synthesis and methods of making the intermediates. Also provided are pharmaceutically acceptable compositions including compounds prepared by the synthetic method and methods of treating disorders using the same.
专利号:US-8828984-B2 优先权日:2012-11-19 标题:Gold(III) complexes containing N-heterocyclic carbene ligand, synthesis, and their applications in cancer treatment and thiol detection 发明人:CHE CHI MING; ZOU TAOTAO 权利人:UNIV HONG KONG; UNIV HONG KONG 摘要:Provided herein is a method of synthesis of Au(III)-NHC complexes, a pharmaceutical composition comprises thereof. Also provided herein are the methods for the treatment and prevention of cancer/tumor in patients in need thereof by the administration of the Au(III)-NHC complexes. Also provided is method of detecting thiol in a biological system. The Au(III)-NHC complexes possess anticancer activity such as the induction of cell death, inhibition of cellular proliferation, inhibition of thioredoxin reductase activity, and inhibition of tumor growth in vivo.
专利号:US-10577387-B1 优先权日:2018-08-09 标题 :Platinum (II) complexes containing N-heterocyclic carbene ligand and pincer ligands, synthesis, and their applications in cancer treatment 发明人:CHE CHI MING; Fung Sin Ki; Chen tian feng 权利人:UNIV HONG KONG 摘要:Provided herein is a method of synthesis of Pt(II) complexes, a pharmaceutical composition comprises thereof. Also provided herein are the methods for the treatment and prevention of cancer/tumor in patients in need thereof by the administration of the Pt(II) complexes. Also provided is a method of detecting the Pt(II) complex in a biological system. Also provided is a method of making the Pt(II) complex The Pt(II) complexes possess anticancer activity such as the induction of cell death, inhibition of cellular proliferation, and inhibition of tumor growth in vivo.
专利号:US-11286271-B2 优先权日:2018-07-31 标 题 :Iridium (III) complexes containing N-heterocyclic carbene ligand, synthesis, and their use thereof in cancer treatment 发明人:CHE CHI MING; LAM TSZ LUNG; TONG KA CHUNG 权利人:UNIV HONG KONG 摘要:Provided herein are Ir(III) complexes comprising N-heterocyclic carbene ligand, method of synthesis of the Ir(III) complexes, a pharmaceutical composition comprises thereof. Also provided herein are the methods for the treatment and prevention of cancer/tumor in patients in need thereof by the administration of the Ir(III) complexes under both dark and light conditions. Also provided is a method of detecting the Ir(III) complex in a biological system. Also provided is a method of making the Ir(III) complex. The Ir(III) complexes possess anticancer activity such as the induction of cell death, inhibition of cellular proliferation, and inhibition of tumor growth in vivo.
专利号:WO-2024262824-A1 优先权日:2023-06-20 标 题 :Novel process for synthesis of polysubstituted pyridine derivatives 发明人:PARK SEUNG BUM; YI SIHYEONG 权利人:SEOUL NAT UNIV R&DB FOUNDATION 摘要:The present invention relates to a novel method for synthesizing a polysubstituted pyridine derivative and, more specifically, to a method for synthesizing a 2,3,5-substituted pyridine derivative through a specific ring cleavage reaction. In the synthesis method of the present invention, an enamine structure is formed in situ by using beta keto ester/sulfone/phosphonic acid ester and ammonium acetate and subjected to an aldol condensation reaction with 3-formyl (aza) indole/benzofuran, a cyclization reaction, and a ring-cleavage reaction in that order to synthesize a characteristic pyridine structure having an alkyl/aryl substituent attached to the 2-position thereof, an ester/sulfone/phosphonic acid ester attached to the 3-position thereof, and ortho-aminoaryl/phenol including various substituents attached to the 5-position thereof. In particular, (aza)indole/benzofuran and beta keto ester/sulfone/phosphonic acid ester, which are reaction substrates, are substrates having very high accessibility, and enable the introduction of various substituents, thereby constructing a pyridine skeleton having high biocompatibility into which ortho-aminoaryl or phenol substituents having various substituents are introduced.
1: Poggi L, Kolesar JM. Vismodegib for the treatment of basal cell skin cancer. Am J Health Syst Pharm. 2013 Jun 15;70(12):1033-8. doi: 10.2146/ajhp120311. Review. Review. doi: 10.1016/j.clinthera.2012.08.011. Epub 2012 Oct 1. Review. doi: 10.1358/dot.2012.48.7.1808490. Review. doi: 10.2165/11209590-000000000-00000. Review. Review.
合成参考文献
参考文献:10.1158/1078-0432.ccr-11-0972 摘要:Lorusso PM, Jimeno A, Dy G, Adjei A, Berlin J, Leichman L, Low JA, Colburn D, Chang I, Cheeti S, Jin JY, Graham RA. Pharmacokinetic dose-scheduling study of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with locally advanced or metastatic solid tumors. Clin Cancer Res. 2011 Sep 01;17(17):5774–82. doi: 10.1158/1078-0432.ccr-11-0972. 参考文献:10.1158/0008-5472.can-11-0923 摘要:Metcalfe C, de Sauvage FJ. Hedgehog fights back: mechanisms of acquired resistance against Smoothened antagonists. Cancer Res. 2011 Aug 01;71(15):5057–61. doi: 10.1158/0008-5472.can-11-0923.